Literature DB >> 20450855

Fever due to inflammation in acute aortic dissection: Description and proposals for diagnostic and therapeutic management.

Eduardo García-Romo1, Francisco López-Medrano, Alfredo Llovet, Manuel Lizasoain, Rafael San Juan, José María Aguado.   

Abstract

Few studies have investigated fever secondary to underlying acute aortic dissection. A retrospective analysis of 59 patients was carried out. Diagnostic criteria for fever secondary to underlying aortic dissection were defined. Five patients had a clinical presentation consistent with inflammatory fever due to acute aortic dissection. The main features were: fever occurred within the first 48 hours, the variability in body temperature was significantly less than with infectious fever (P=.015), episodes of fever did not affect the patient's general clinical condition, microbiological tests gave negative results, there was no response to empirical antimicrobial treatment, and fever disappeared within 24 hours in those treated with indomethacin. In conclusion, fever due to acute aortic dissection has distinct characteristics that enable it to be distinguished from infectious fever. Good management of this condition should not involve unnecessary diagnostic tests, the inappropriate use of antimicrobials, or a delay in applying the therapeutic measures necessary to treat the underlying aortic dissection.

Entities:  

Mesh:

Year:  2010        PMID: 20450855     DOI: 10.1016/s1885-5857(10)70123-7

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  2 in total

1.  Pyrexia in patients with uncontrolled systemic hypertension: could they have an aortic dissection?

Authors:  Vasileios Patris; Jennifer Whiteley; Orestis Argiriou; Niki Lama; Haris Georgiou; Charalampos Constantinou; Mihalis Argiriou; Christos Charitos
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

Review 2.  Fever of unknown origin in aortic dissection.

Authors:  S-M Yuan
Journal:  Z Rheumatol       Date:  2017-05       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.